Aminobenzoic acids and derivatives
TARGETMOL CHEMICALS INC Cecropin A 1MG
Also available in 5 mg, 10 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. Cecropin A, a linear 37-residue antimicrobial polypeptide produced by the cecropia moth, has exhibited cytotoxicity in various human cancer cell lines and inhibitory effects on tumor growth. Purity 96.78%
TARGETMOL CHEMICALS INC Levistolide A 20MG
Also available in 1 mL and bulk. Please contact Fisher for quotes. 1. Levistolide A (Diligustilide) inhibits liver fibrosis and angiogenesis. Purity 98.94%
Chemscene 4-Ethoxy-4-oxobutanoic acid | 5g | CS-W013313 | 98% | 1070-34-4 | MFCD00053346 | 146 14 | C6H10O4
Chemscene | 4-Ethoxy-4-oxobutanoic acid | 5g | CS-W013313 | 98% | 1070-34-4 | MFCD00053346 | 146 14 | C6H10O4
Chemscene Sorbic acid | 500g | CS-0009618 | 98% | 110-44-1 | MFCD00002703 | 112 13 | C6H8O2
Chemscene | Sorbic acid | 500g | CS-0009618 | 98% | 110-44-1 | MFCD00002703 | 112 13 | C6H8O2
Medchemexpress LLC 7-ketolithocholic acid | 4651-67-6 | MFCD00271393 | 99.9% | 390.56 g/mol | C24H38O4 | 5 G
7-Ketolithocholic acid is a bile acid research standard (3α-hydroxy-7-oxo-5β-cholanic acid) used in biochemical and metabolic studies. Supplied as a solid or as a DMSO solution, it is intended for in vitro research applications investigating bile acid metabolism and cholesterol secretion.
- High purity suitable for research use.
- White to off-white solid appearance.
- Soluble in DMSO (≥ 100 mg/mL).
- Stable under recommended storage conditions.
- Includes molecular formula and molecular weight for analytical reference.
Medchemexpress LLC 9-Amino-NeuAc | 153232-60-1 | C11H20N2O8 | 1 MG
9-Amino-NeuAc is a substrate of synthase that can be converted to CMP9-amino-NeuAc, which is then activated to the corresponding CMPglycoside and transferred to asialoglycoprotein. This compound can also be used to target liposome synthesis while modulating tumor surface immunogenicity.
- Functions as a substrate of synthase
- Converts to CMP9-amino-NeuAc
- Activated to CMPglycoside
- Transferred to asialoglycoprotein
- Targets liposome synthesis
- Modulates tumor surface immunogenicity
Chemscene 1 3-Benzothiazol-5-amine | 5g | CS-W007552 | 98% | 1123-93-9 | MFCD04115282 | 150 21 | C7H6N2S
Chemscene | 1 3-Benzothiazol-5-amine | 5g | CS-W007552 | 98% | 1123-93-9 | MFCD04115282 | 150 21 | C7H6N2S
Selleck Chemical LLC Amino-PEG1-C2-acid S1872-1g
Amino-PEG1-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs
Chemscene 4-Amino-2 5-difluorobenzonitrile | 5g | CS-W016277 | 98% | 112279-61-5 | MFCD00190102 | 154 12 | C7H4F2N2
Chemscene | 4-Amino-2 5-difluorobenzonitrile | 5g | CS-W016277 | 98% | 112279-61-5 | MFCD00190102 | 154 12 | C7H4F2N2
Chemscene 4-Hydroxy-3-(trifluoromethyl)benzonitrile | 5g | CS-W003349 | 98% | 124811-71-8 | MFCD06797882 | 187 12 | C8H4F3NO
Chemscene | 4-Hydroxy-3-(trifluoromethyl)benzonitrile | 5g | CS-W003349 | 98% | 124811-71-8 | MFCD06797882 | 187 12 | C8H4F3NO
Medchemexpress LLC Sns-314 mesylate | 1146618-41-8 | ≥98.0% | 25 MG
SNS-314 mesylate is the mesylate salt of SNS-314, a potent pan-Aurora kinase inhibitor active against Aurora A, B, and C used in preclinical research to investigate mitotic regulation and antineoplastic mechanisms.
- Potent inhibition of Aurora A, B, and C (IC50 ≈ 9, 31, and 6 nM)
- High purity: ≥98%
- Powder form, soluble in DMSO for screening and formulation
- Typical storage: -20 °C to preserve stability
- Provided as mesylate salt; formula C18H15ClN6OS2 • CH3SO3H, formula weight 527.0
Medchemexpress LLC Naquotinib mesylate | 1448237-05-5 | 98.06% | 658.81 | 50 MG
Naquotinib mesylate is an orally available, mutant-selective and irreversible EGFR inhibitor. It shows potent inhibition against EGFR mutants with IC50s of 8-33 nM, and 230 nM for wild-type EGFR. It has demonstrated efficacy in inhibiting cell growth and inducing tumor regression in various xenograft models.
- Orally available and mutant-selective
- Irreversible EGFR inhibitor
- Potent inhibition of EGFR mutants (8-33 nM IC50)
- Inhibits phosphorylation of EGFR and downstream signaling pathways (ERK and Akt)
- Induces tumor regression in xenograft models
Medchemexpress LLC Eprosartan mesylate | 144143-96-4 | MFCD08141807 | 100.0% | 520.62 g/mol | C24H28N2O7S2 | 10 MG
Eprosartan mesylate is a selective, competitive, orally active angiotensin II receptor antagonist supplied for research use in pharmacology and biochemical studies. It is provided as a high-purity solid and as solution formulations for in vitro assays, and is supported by technical documentation (datasheet, COA, SDS) for laboratory handling and experimental planning.
- Selective angiotensin II receptor antagonist suitable for receptor binding and functional assays.
- High purity appropriate for research applications (listed at 99.95%).
- Available as a solid and as a 10 mM solution in DMSO for in vitro use.
- Supported by datasheet, certificate of analysis, and safety data sheet.
- Stable when stored sealed and protected from moisture; specific solvent storage conditions available.
Apexbio Technology LLC Delavirdine mesylate 147221-93-0 100mg
Delavirdine mesylate (CAS 147221-93-0) is a small-molecule inhibitor targeting HIV-1 reverse transcriptase It is designed to selectively inhibit the enzymatic activity of HIV-1 reverse transcriptase thereby disrupting viral DNA synthesis and impeding HIV replication Delavirdine mesylate exerts its biological activity primarily through direct binding to an allosteric site on HIV-1 reverse transcriptase In biochemical studies delavirdine mesylate demonstrates inhibitory activity against HIV-1 reverse transcriptase with an IC50 value of 0 26 M Based on these pharmacological properties delavirdine mesylate holds research potential in antiviral assays HIV resistance studies and mechanistic investigations into NNRTI-related enzyme inhibition